In debt-to-equity swap, banks led by SBI are expected to gain 30 per cent stake in Jet Airways. On the other hand, the airline is fighting severe liquidity crunch with lessors grounding five aircraft belonging to its fleet at metro airports.

Based on the request of Religare Enterprises, the India Ratings & Research Private Limited (IND Ra) has withdrawn the company’s ratings on its debt instruments.

Overall volumes in futures & options currently stand at 1.38 crore contracts with a turnover of Rs. 8,55,503.65 crore.

Kingfa Science & Technology Ltd. reported its results for the quarter ended December 31, 2018 after  market hours yesterday.

Overall volumes in futures & options currently stand at 1.38 crore contracts with a turnover of Rs. 8,55,503.65 crore.

Going ahead, Nifty needs to hold the Doji candle's low of 10,584 to keep the pullback options open towards 10,750 level, as failure to do so would result in extension of corrective decline towards the level of 10,550. Stocks in news: Yes Bank, Coromandel International, Asian Paints and DCM Shriram.

Indian markets are likely to open largely unchanged as cues from Asian peers are dull. The SGX Nifty indicates Nifty is likely to open almost unchanged around 10,697. Ajanta Pharma, Bajaj Auto, BEL, Castrol India, ICICI Bank, Hexaware, IOC, Jubilant Foodworks, LIC Housing Finance, NTPC, Torrent Pharma will declare their results today. 

KEC International reported its results for the quarter ended December 31, 2018 on Tuesday. The company's consolidated revenue for the quarter came in at Rs. 2,646.63 crore as against Rs. 2404.75 crore in the corresponding quarter last year, registering 10.1 per cent YoY increase.

India has become the second largest steel producing country as its crude steel production in 2018 surpassed Japan’s production. In 2018, Japan Produced around 104.3 MT steel. India's steel output was at 106.5 MT in 2018, up by 4.9 per cent from 101.5 MT in 2017.

Strides Pharma Science’s step-down subsidiary Strides Pharma Canada has entered into an arrangement to acquire 80 per cent stake in Pharmapar Inc., a Canada-based specialised generics front-end company. Canada is a new market for the company and one of top 10 global pharmaceutical markets.